Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (172)	5/31/2001 9:48:45 AM
From: aknahow	Read Replies (2) \| Respond to of 1022

No, not that. At the annual meeting, the Biosite disagreement was brought up. (No idea of which company is correct or will prevail), and the answer was about 13 more companies, in the phage area are looking at licensing agreements. Inference was 6 were close to signing. Xoma apparently believes that its technology is being used by companies working with phages. My interest is in trying to get some idea about the overall size of this market. One can listen to the presentation and there are other points of interest such as XOMA views on Xanelim for psoriasis.